Johnson & Johnson pauses coronavirus vaccine trials after unexplained illness

United States News News

Johnson & Johnson pauses coronavirus vaccine trials after unexplained illness
United States Latest News,United States Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 46 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 97%

The drug maker announced Monday night that the 60,000-patient, late-stage trials have been put on hold and new enrollment has been halted, citing “an...

Johnson & Johnson has paused clinical trials for its COVID-19 vaccine candidate after an unexplained illness by a participant

The drug maker announced Monday night that the 60,000-patient, late-stage trials have been put on hold and enrollment has been halted, citing “an unexplained illness in a study participant.” J&J JNJ, +0.57% noted that such pauses “are not uncommon in clinical trials,” and said there would be “a careful review of all of the medical information before deciding whether to restart the study.”

Rival AstraZeneca AZN, +1.00% paused the late-stage trials of its coronavirus vaccine candidate in early September after an unexplained illness by a participant in the U.K. Regulators in the U.K., Brazil, India and South Africa have since allowed AstraZeneca’s trials to resume, though it remains on hold in the U.S. as the Food and Drug Administration has widened its investigation.

There are seven coronavirus candidates being tested in the U.S., with at least four moving to late-stage trials.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Johnson & Johnson coronavirus vaccine trials paused - Business InsiderJohnson & Johnson coronavirus vaccine trials paused - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »

COVID-19 antibodies last at least three months; so do symptoms for manyCOVID-19 antibodies last at least three months; so do symptoms for manyThe following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Read more »

Johnson has lost control of coronavirus, says LabourJohnson has lost control of coronavirus, says LabourBritish Prime Minister Boris Johnson has lost control of the coronavirus crisis and while further restrictions are necessary they should be accompanied with additional financial help, opposition Labour's pensions policy chief said on Sunday.
Read more »

Turning local, British PM Johnson to unveil new coronavirus rulesTurning local, British PM Johnson to unveil new coronavirus rulesBritish Prime Minister Boris Johnson is expected to announce new measures to tackle a growing coronavirus crisis on Monday, moving to work more closely with local leaders from England's worst affected areas.
Read more »

Russia says human trials of its coronavirus vaccine have begun in the Middle EastRussia says human trials of its coronavirus vaccine have begun in the Middle EastRussia has announced that human trials of its controversial coronavirus vaccine have begun in the United Arab Emirates.
Read more »

UK Prime Minister Boris Johnson to announce latest measures to tackle coronavirus in EnglandUK Prime Minister Boris Johnson to announce latest measures to tackle coronavirus in EnglandUK Prime Minister Boris Johnson is set to announce a new system of Covid-19 alert levels in England as authorities try to curb rising numbers of infections in the country, according to a government statement.
Read more »



Render Time: 2025-02-25 13:52:33